Seerlinq posúva neinvazívnu diagnostiku, monitorovanie chorôb a optimalizáciu liečby na novú úroveň využívaním najmodernejšej analýzy PPG pomocou strojového učenia a našich lekárskych odborností. Naše výskumy naznačujú, že momentálne iba škrabeme povrch jej možností. Znovuobjavujeme spôsob pohľadu na PPG krivku využitím umelej inteligencie na komplexnú analýzu všetkých nameraných parametrov. Okrem toho využívame našu celosvetovú sieť lekárov a klinických výskumníkov na zber lekársky označených údajov. Využívame naše odborné znalosti v oblasti zberu, spracovania a modelovania údajov na dosiahnutie bezprecedentných výsledkov.
Prihlásiť sa na odber noviniekSme schopní spracovať surové údaje PPG z rôznych zdrojov a zariadení na pohon našich diagnostických algoritmov.
PPG took the world by storm, and nowadays, it is used not only in hospitals but also in consumer wearables to monitor, e.g., your heart rate or oxygen saturation.
PPG is one of the most widespread physiological monitoring available to the general public and most of you probably already use it: in your smartwatches, fitness bands or chest straps. It is used to detect blood volume changes in the microvascular bed of tissues. It is non-invasive, low cost and in terms of basic vitals relatively easy to analyze. However, precisely medically labeled data from variety of patients and clinical settings is needed to study and analyze more complex signal patterns which can detect and monitor various cardiovascular diseases and even predict their progression.
We at Seerlinq collect medically labeled data from a great variety of cardiovascular patients and healthy individuals in different clinical settings to able to utilize PPG signal to its maximal potential. In order to guarantee the universality of our solution, we use several different devices including our dedicated HW for data collection.
We employ numerous steps from the world of signal processing, statistics, and machine learning to ensure the data we work with are ready for diagnosis and monitoring.
Processing of PPG data relies on signal processing algorithms and implementation. What you typically want is to have your signal clean and ready for diagnostics and health monitoring. There are many possible steps involved in signal processing, and we do them all: we apply digital filters to extract the spectral components of our interest, we denoise the data using advanced techniques such as empirical mode decomposition or auto-encoding denoisers.
We can detect artifacts or individual heart beats within the signal, we can extract features for later diagnostic models, compute derivatives and many more. Moreover, our signal processing codebase is designed in a block-wise fashion with modularity in mind, allowing for rapid prototyping and simple deployment of processing pipelines. We also employ state-of-the-art optimization algorithms to accommodate any PPG hardware.
Seerlinq's primary mission is to deliver predictive algorithms for various cardiovascular diseases leveraging state-of-the-art machine learning methods.
Diagnostika a monitorovanie
We believe that wide implementation of this solution will lead to reduced mortality, fewer hospitalizations and in-person ambulatory visits, better comfort, and overall quality of life for heart failure patients. Utilizing methods of digital and precision medicine has been furthermore associated with improved self-care, therapy adherence, reduction of depressive and anxiety symptoms and overall sensation of being in control of the disease process. On a wider scale such optimization is associated with decreased overload, improved efficiency, and cost reduction for healthcare systems.
PPG is one of the most widespread physiological monitoring available to the general public and most of you probably already use it: in your smartwatches, fitness bands or chest straps. It is used to detect blood volume changes in the microvascular bed of tissues. It is non-invasive, low cost and in terms of basic vitals relatively easy to analyze. However, precisely medically labeled data from variety of patients and clinical settings is needed to study and analyze more complex signal patterns which can detect and monitor various cardiovascular diseases and even predict their progression.
We at Seerlinq collect medically labeled data from a great variety of cardiovascular patients and healthy individuals in different clinical settings to able to utilize PPG signal to its maximal potential. In order to guarantee the universality of our solution, we use several different devices including our dedicated HW for data collection.
Processing of PPG data relies on signal processing algorithms and implementation. What you typically want is to have your signal clean and ready for diagnostics and health monitoring. There are many possible steps involved in signal processing, and we do them all: we apply digital filters to extract the spectral components of our interest, we denoise the data using advanced techniques such as empirical mode decomposition or auto-encoding denoisers.
We can detect artifacts or individual heart beats within the signal, we can extract features for later diagnostic models, compute derivatives and many more. Moreover, our signal processing codebase is designed in a block-wise fashion with modularity in mind, allowing for rapid prototyping and simple deployment of processing pipelines. We also employ state-of-the-art optimization algorithms to accommodate any PPG hardware.
During our unique proprietary research, we noticed subtle changes in photoplethysmography (PPG) signal, correlating with heart failure progression. Immediately, we realized the potential for non-invasive monitoring and prediction of disease progression in HF patients, opening the doors to the new frontiers in predictive medicine. Seerlinq transforms any device capable of acquiring PPG into a potentially powerful telemedical tool.
We believe that wide implementation of this solution will lead to reduced mortality, fewer hospitalizations and in-person ambulatory visits, better comfort, and overall quality of life for heart failure patients. Utilizing methods of digital and precision medicine has been furthermore associated with improved self-care, therapy adherence, reduction of depressive and anxiety symptoms and overall sensation of being in control of the disease process. On a wider scale such optimization is associated with decreased overload, improved efficiency, and cost reduction for healthcare systems.
Tím Seerlinq sa skladá z rôznorodých profesionálov nadšených zlepšovaním zdravotnej starostlivosti pomocou moderných a inovatívnych technológií.
Čítajte novinky o našej práci na spracovateľských algoritmoch, vývoji prototypov nositeľných zariadení a klinických štúdiách na detekciu kardiovaskulárnych chorôb.
S hrdosťou oznamujeme, že Seerlinq je teraz certifikované ako zdravotnícke zariadenie triedy II(b) podľa nariadenia EÚ MDR 2017/745!
K nášmu programu pripojilo už viac než 200 pacientov a spolupracujeme s viac než 50 lekármi po celom Slovensku!
Seerlinq is proud to be recognized in Deloitte Technology Fast 50 CE 2024, celebrating our innovation in healthcare!
We are still working on our research to improve the quality of our techcnology.
Ak máte akékoľvek otázky ohľadom Seerlinq, chcete s nami spolupracovať alebo ste jednoducho zvedaví, neváhajte nás kontaktovať!
Seerlinq s.r.o.